INJ is hovering around $6.60, stuck in a downtrend that's been dragging on for weeks. The chart paints a clear picture: lower highs and failed rallies. Buyers just can't seem to gain any ground. Momentum is flat, and volatility suggests a slow decline, not a sudden turnaround.

The RSI, at 36, isn't screaming "oversold." Instead, it indicates constant pressure. Rallies fizzle fast, and resistance levels hold strong. The long-term numbers are hard to ignore: -20% over the last 30 days, -54% over 90 days, and a whopping -74% over the past year. This isn't just a temporary dip; it's a deeper issue.

But, the last few days offer a glimmer of hope. The price seems to be stabilizing. This is often where the market pauses to re-evaluate risk. Liquidity dries up, and the stage is set for the next big move. Momentum is weak, but the tension is building. Keep a close eye on how INJ behaves around this level. Will it try a short-term bounce, or will it continue its slow slide? @Injective #injective $INJ

INJUSDT

Perp

6.246

-3.17%